Management
Management Team
Home Preeclampsia Technology Intellectual property Management News Contact

James Smith, Ph.D. - CEO/President

Dr. Smith has over fifteen years of experience in regulatory affairs and the development of novel technologies from concept through commercialization. He is experienced in all aspects of regulatory affairs, quality and data management systems, supervision of R&D, development of new product specifications, and with evaluating and registering medical drug and device product lines. Dr. Smith obtained his Ph.D. in Pharmacology and Toxicology from the University of California, Irvine.

Henry Smith, Ph.D. - Chairman of the Board

Dr. Smith has over forty years of experience in the healthcare industry. He was the co- founder of several biotechnology companies and medical laboratories including NanoSmart Pharmaceuticals, Epinex Diagnostics, Allied Biotechnology International, and Associated Reference Laboratories. Earlier, he held senior management positions in medical reference laboratories including Specialty Labs and BioScience Laboratories. Dr. Smith received his training in Immunology from the University of Leeds Medical School in England. Throughout his career he has maintained an active interest in developing novel immunoassays and immunotherapies for autoimmune disease and cancer.

Dan Thiel - VP, Business Development

Mr. Thiel has over ten years of experience in the biotechnology industry providing services in business development, fund raising, corporate finance, investor relations, strategic planning, marketing and public relations for early-stage development companies. Mr. Thiel received his B.S. in Business from Miami University in Oxford, Ohio, with a concentration in international business at Universidad de Las Americas in Puebla, Mexico.

Nihar R. Nayak, DVM, Ph.D. - Advisor

Dr. Nayak is currently an Associate Professor of Obstetrics and Gynecology (Research) and the Director of Translational Research in the Division of Maternal Fetal Medicine at the Stanford University School of Medicine. After receiving DVM and PhD degrees from India, Dr. Nayak obtained his postdoctoral training from the Oregon Health and Science University, Portland. Previously, he has served as an Assistant Professor in a School of Veterinary Medicine in India, a Staff Scientist at the Oregon National Primate Research Center and a Senior Scientist at Stanford University. Dr. Nayak has received several research awards, including the Lalor Foundation postdoctoral fellowship, the Andrew Mellon Foundation Junior Investigator Award, the NIH BIRCWH award, and the Preeclampsia Foundation Vision Grant Award. One of his major research goals is to understand vascular complications during pregnancy, particularly in preeclampsia, and to develop novel therapies for preeclampsia.

Targeted Therapy for Preeclampsia

Copyright © 2013     Advanced Prenatal Therapeutics, Inc  Terms of Use Privacy Policy
Scientific Advisory Board
Management